3billion, Inc. (KOSDAQ:394800)

Market Cap	187.16B
Revenue (ttm)	6.85B
Net Income (ttm)	-6.51B
Shares Out	31.72M
EPS (ttm)	-219.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	95,914
Average Volume	191,130
Open	6,060.00
Previous Close	5,970.00
Day's Range	6,050.00 - 6,180.00
52-Week Range	3,025.00 - 8,280.00
Beta	n/a
RSI	33.37
Earnings Date	n/a

About 3billion

3billion, Inc. develops technology for rare disease drug discovery using bioinformatics and machine learning technology. The company focuses on developing methods for novel drug target discovery, drug candidate generation, and safety assessment. It offers genetic and biomolecular testing services related to the analysis of biologic samples of patients suspected to have rare genetic disorders, as well as provides various affiliated services to customers. The company was founded in 2016 and is based in Seoul, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 394800

Financial Performance

In 2024, 3billion's revenue was 5.77 billion, an increase of 111.41% compared to the previous year's 2.73 billion. Losses were -6.57 billion, 29.1% more than in 2023.